Comparing open vs closed thawing systems

https://www.lingan-bio.com/products/la-c003-vial-ampoule-water-free-cell-thawer.html

Comparing Open vs. Closed Thawing Systems

The choice between open and closed thawing systems has become a critical decision point for laboratories handling cell therapies, primary cells, and other biopharmaceutical products. While traditional open thawing in water baths remains common, closed and functionally closed systems are rapidly gaining adoption in clinical and Good Manufacturing Practice (GMP) environments. Understanding the trade-offs between these approaches is essential for maintaining product quality, ensuring regulatory compliance, and protecting patient safety.

Defining Open and Closed Thawing

Open thawing systems refer to methods where the cryopreserved container—whether a vial or bag—is directly exposed to the external environment during the thawing process. The conventional water bath is the quintessential open system: the container is submerged in non-sterile water, then removed, dried, and wiped with alcohol before entering a biosafety cabinet. Throughout this process, the container exterior contacts non-sterile surfaces, and the potential for water ingress around seals creates contamination risk .

Closed thawing systems, by contrast, maintain a sealed or protected environment throughout the thawing process. These systems use dry heating methods—warmed gel pads, circulating heated fluid in a closed loop, or metal heating plates—that never contact the container with water. Some systems function as "functionally closed," where the container remains sealed while heating elements transfer energy through the container walls without any breach of sterility .

A distinction also exists between fully closed systems (never exposed to the external environment during processing) and functionally closed systems (periodically opened under controlled conditions). For thawing specifically, most automated dry systems are functionally closed, as the container remains sealed throughout the procedure .

Contamination Risk: The Fundamental Differentiator

The most significant difference between open and closed thawing systems lies in contamination risk. Open water baths present multiple contamination pathways that are well-documented in the literature.

Water baths develop biofilms over time, even with regular cleaning and biocide treatment. These biofilms harbor environmental bacteria including Bacillus, Staphylococcus, Pseudomonas, and Enterococcus species—many of which originate from human skin flora . When cryobags or vials are submerged, the container exterior becomes contaminated. If seals are compromised—a particular risk for cryobags stored long-term—water can seep inside, destroying the product and potentially contaminating other samples in the same water bath.

The scale of this risk is substantial. One report documented microbial contamination affecting up to 40% of adipose-derived stem cell batches intended for therapeutic use when processed using open methods . For cell therapies where each batch represents an individual patient's treatment, contamination leading to batch rejection has serious consequences: loss of the only treatment opportunity for that patient and potential delays in care.

Closed thawing systems eliminate water-borne contamination entirely. The Barkey Plasmatherm C&G, for example, uses a closed-loop fluid circulation system where warming fluid never contacts the container. The cushions that embrace the cryobag or vial are sealed, and the system requires only annual water replacement . Similarly, the ThawMaster-B uses water-free dry heating technology with infrared thermal imaging, providing a completely non-liquid thawing environment that prevents changes in osmotic pressure and eliminates water-borne contamination risks .

A 2002 comparative study of water bath versus dry warming for cryopreserved mobilized peripheral blood found that while both methods produced equivalent viability results, "the potentially decreased risk of bacterial contamination of either the cell product or the patient room, and guidelines of good clinical practice (GCP), favor the use of the dry warming procedure" .